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Hypoxic-ischemic encephalopathy (HIE) at birth could cause cerebral palsy (CP), mental
retardation, and epilepsy, which last throughout the individual’s lifetime. However, few
restorative treatments for ischemic tissue are currently available. Cell replacement therapy
offers the potential to rescue brain damage caused by HI and to restore motor function.
In the present study, we evaluated the ability of embryonic stem cell-derived neural
progenitor cells (ES-NPCs) to become cortical deep layer neurons, to restore the neural
network, and to repair brain damage in an HIE mouse model. ES cells stably expressing
the reporter gene GFP are induced to a neural precursor state by stromal cell co-culture.
Forty-hours after the induction of HIE, animals were grafted with ES-NPCs targeting the
deep layer of the motor cortex in the ischemic brain. Motor function was evaluated
3 weeks after transplantation. Immunohistochemistry and neuroanatomical tracing with
GFP were used to analyze neuronal differentiation and axonal sprouting. ES-NPCs
could differentiate to cortical neurons with pyramidal morphology and expressed the
deep layer-specific marker, Ctip2. The graft showed good survival and an appropriate
innervation pattern via axonal sprouting from engrafted cells in the ischemic brain. The
motor functions of the transplanted HIE mice also improved significantly compared
to the sham-transplanted group. These findings suggest that cortical region specific
engraftment of preconditioned cortical precursor cells could support motor functional
recovery in the HIE model. It is not clear whether this is a direct effect of the engrafted
cells or due to neurotrophic factors produced by these cells. These results suggest
that cortical region-specific NPC engraftment is a promising therapeutic approach for
brain repair.
Keywords: hypoxic-ischemic encephalopathy, embryonic stem cell, transplantation, regeneration, integration,
Ctip2, motor function
INTRODUCTION
Hypoxic-ischemic encephalopathy (HIE) represents a major
cause of brain damage in the fetus and newborn infants, occur-
ring in about 20 per 1000 term live birth, and in nearly 60%
of very low birth weight newborns (MacDonald et al., 1980;
Gunn, 2000). It is suggested that up to 25% of the survivors have
permanent and varied neurological deficits, including cerebral
palsy (CP), mental retardation, learning disability, and chronic
epilepsy (Vannucci, 2000; Volpe, 2001; Ferriero, 2004). These
deficits can severely impair the patients’ ability in their daily life
(ADL) throughout their lifetime (Perlman, 2006).
Hypoxic ischemia (HI) stress triggers neuronal and glial
injury leading to necrosis secondary to cellular edema, lysis,
and the resulting apoptosis in delayed cellular injury (Delivoria-
Papadopoulos and Mishra, 1998; Nakajima et al., 2000;
Northington et al., 2001). These cellular injuries tended to occur
in the subplate neurons and resulted in periventricular leukoma-
lacia (PVL) due to immaturity of the cerebral vasculature or its
vulnerability (Volpe, 2001; McQuillen et al., 2003). The cortex
is partitioned into distinct regions that serve different functions,
such as vision, touch, hearing, and movement. Each of these areas
is composed of six layers of glutamatergic pyramidal neurons
with distinct firing patterns, specific axonal and dendritic pro-
jection patterns (Connors and Gutnick, 1990; Tseng and Prince,
1993), and unique gene expression profiles including bHLH tran-
scriptional factors, such as neuroD, neuroD2, and Math2, which
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are all expressed in newborn cortical projection neurons at least
transiently, and also two T-domain transcriptional factors, Tbr2
and Tbr1, are expressed sequentially in many projection neurons
during differentiation (Hevner, 2006). These neurons degener-
ate in amyotrophic lateral sclerosis (ALS) which mainly affects
late onset motor neurons (Boillee et al., 2006), in spinal cord
injury which induces apoptosis of cortical projection neurons
(Hains et al., 2003), and also in HIE which induces cortical lam-
inar necrosis, predominantly in pyramidal cell layers III or V
(Armstrong et al., 2007). With the exception of hypothermia,
there is no specific effective treatment which could rescue HIE
patients (Gluckman et al., 2005; Perlman, 2006). An effective
therapy is needed to treat these patients.
Cell replacement therapy offers the prospect to rescue dam-
aged tissue, to replace lost cells, and restore neurological func-
tion after HI encephalopathy. Embryonic stem (ES) cells possess
attractive features as a limitless cell source to create the myriad
of cell types found in the body. The finding that neurons can be
generated from ES cells has led to the expectation that neurolog-
ical pathologies, such as Parkinson’s disease (PD), ALS, stroke,
or spinal cord injury will be treatable using cell-based transplan-
tation strategies (Muotri and Gage, 2006; Suzuki and Svendsen,
2008). Neural stem cell-based therapy is also an attractive novel
therapy for neonatal HIE, but not much research as been done in
this area (Daadi et al., 2010).
One would hypothesize that when using a cell-based therapy
for HIE, motor functional recovery could be achieved with the
replacement of injured cortex by implantation of pyramidal neu-
ronal progenitor cells and that the cortical area-specific axonal
projections to the subcortical area would recapitulate the normal
adult structure.
In the present study, we evaluated functional recovery
after implantation of ES cell-derived neuronal progenitor cells
(ES-NPCs) into a neonatal HIE model. We also investigated
whether the implanted cells can generate deep layer cortex-
specific pyramidal neurons and recapitulate an area-specific neu-
ronal network based on axonal projections from the implanted
cells.
MATERIALS ANDMETHODS
ANIMALS AND EXPERIMENTAL GROUPS
Pregnant mice were purchased from Japan SLC (Shizuoka,
Japan). Two day-old neonatal ICR mouse pups were ran-
domly assigned to the following four groups: (1) Naïve con-
trol group (no operative procedure), (2) HI control group
(HI only, no transplantation), (3) vehicle-transplantation group
(HI and vehicle-transplantation), (4) Transplantation group (HI
and NPC-transplantation). Animal experiments were performed
in accordance with the guidelines of Yamaguchi University
and the NIH Guide for the Care and Use of Laboratory
Animals.
CELL PREPARATION
The F7 cell line, which was generated from the ES cell line
E14Tg2a.4 and contained the inserted green fluorescent pro-
tein (GFP) expressing gene, was cultured as previously described
(Ideguchi et al., 2008). Briefly, cells were plated at low density,
106 per 10 cm dish coated with gelatin (Millipore Bioscience
Research Reagents; ES-006-B), for 10 days in “Maintenance
medium” consisting of Glasgow modified Eagle’s medium
(GMEM; Sigma) supplemented with 10% FBS (Hyclone), 2mM
L-glutamine (Gibco-Invitrogen), 0.1mM non-essential amino
acid (NEAA;Gibco-Invitrogen), 1mM sodium pyruvate (Sigma),
0.1mM 2-mercaptoethanol (Sigma), and 2000 units/ml leukemia
inhibitory factor (LIF; Esgro, Chemicon) under Geneticin selec-
tion (1.5μg/ml; Invitrogen). ES cells were induced to a neural
precursor state by co-culture with themouse stromal cell lineMS5
(Kirin Pharma) (Barberi et al., 2003). “MS5 medium” consisted
of αMEN (Gibco) supplemented with 10% fetal bovine serum
(FBS; Sigma) for 7 days. Briefly, a confluent plate of MS5 cells
were treated with mitomycin C (2μg/ml) for 2 h, washed, disso-
ciated, and plated onto gelatin-coated 10 cm dishes. The next day,
104 ESCs were added and cultured in “Differentiation medium”
consisting of GMEM (Gibco-Invitrogen) supplemented with
10% Knockout Serum Replacement (KSR; Gibco-Invitrogen),
2mM L-glutamine, 0.1mM NEAA, 1mM sodium pyruvate,
and 0.1mM 2-mercaptoethanol. FGF2 (fibroblast growth fac-
tor 2; R&D Systems) at 20 ng/ml was added for the last
2 days and resulted in increased numbers of cortical pyra-
midal neurons. ES-NPC colonies were removed by incubation
in Ca22+, Mg2+-free HBSS (15mM HEPES) for 30–45min.
These ES-NPC colonies were dissociated in papain (Worthington
Biochemicals) for 20min at 35◦C and triturated into a single-
cell suspension. The dissociated ES-NPCs were either plated
for immediate immunostaining or further differentiated into
mature neural cells after plating at 1.5 × 105 cells in 500μl
of NB media (Neurobasal and B27; Invitrogen) in each well.
Eight-well chamber slides (Falcon; BD Biosciences Discovery
Labware) were coated with polyornithine (100 ug/ml) followed
by fibronectin (100 ug/ml) (Millipore) before use. The ES-NPCs
were allowed to differentiate for 7 days and then fixed in 4%
paraformaldehyde.
HYPOXIA-ISCHEMIA MODEL
The model used in this study was based on the Rice-Vannucci
model (Vannucci and Vannucci, 1997). Pups were housed with
the dam under a 12:12 h light-dark cycle, with food and water
available ad libitum throughout the studies. On postnatal day 2,
the pups were anesthetized by inhalation with halothane (induc-
tion at 4% and then maintained at 1.0–1.5%), 70% nitrous oxide,
and 30% oxygen. The mice were incised at the midline in a lin-
ear fashion from the infragnathia to the sternum. Then, the right
common carotid artery (CCA) was exposed and ligated with 10-0
nylon thread at two points. Between the ligated points, the CCA
was cut after treatment with a bipolar coagulator®. After the oper-
ation, the pups were returned to the holding container which was
maintained at a temperature of 37◦C and they were allowed to
recover from anesthesia for 1–2 h. Then, they were placed in a
humidified chamber in a 37◦Cwater bath perfused with a hypoxic
gas mixture (8% oxygen, 92% nitrogen) for 20min. All surviving
pups were returned to their dams after hypoxic exposure. From
the time of the operation to the hypoxia treatment, the pups were
continuously kept at a temperature of 37◦C (HI model mouse
group; n = 12, control normal mouse group;n = 12).
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TTC-LABELING METHOD
At 24 h postoperative, the mice were anesthetized and sacrificed
by rapid decapitation. One mm thick coronal brains sections
were cut using a mouse brain matrix (Activation Systems, Inc.),
and sections were immersed in 2% 2,3,5-triphenyltetrazolium
chloride (TTC; Sigma Chemical Co) in 0.9% saline solution, as
described (Bederson et al., 1986).
TRANSPLANTATION
Dissociated day 7-differentiated ES-NPCs were transplanted into
the right cerebral cortex of P4 neonatal mice. Two days after
the induction of HI, animals were placed in a stereotaxic appa-
ratus with a neonatal mouse adaptor. Pups were anesthetized
systemically by inhalation of 4.0–1.0% halothane. After a mid-
line linear skin incision was made, the skull bregma was deter-
mined and a single cell suspension (50,000 cells/μL) of ES-NPCs
was transplanted using a fine tipped, sterile glass pipette into
4 sites (1μL/site) in the right ischemic hemisphere targeting to
the motor cortex [from the bregma: (1) antero-posterior (AP)
0mm, lateral (L) 0.5mm; vertical (V) 0.5mm; (2) AP 0mm, L
1.5mm, V 0.5mm; (3) AP 1.0mm, L 0.5mm, V 0.5mm; (4)
AP 1.0mm, L 1.5mm, V 0.5mm] over several minutes (n = 10).
Sham transplantation was performed as a control using the sur-
gical procedure itself (n = 10). The skin was closed with tissue
adhesive (Vetbond 3M) and the pups were resuscitated under a
warming lamp. Three weeks after transplantation, mice were per-
fused transcardially. Brains were removed and sectioned at 60 um
thickness. Free-floating sections were immunostained with the
indicated primary antibodies and appropriate secondary antibod-
ies, as described below. DAB (Sigma, D5905) enhancement was
used to visualize the graft of the GFP-positive cells. The histo-
logical images were acquired on a Keyence BZ-9000 fluorescence
microscope (Keyence, Osaka). The number of CTIP2-positive
cells in five arbitrary squares (200 × 200 μm) per randomly
selected region of layer V area in each section was counted in every
third section, and we calculated the average number of positive
cells in the unit area (4.0 × 104 μm2). A total of at least 40 areas
were counted per data point. Image joint and dynamic cell count
software (Keyence, Osaka) was used to measure the cortex area,
respectively as described previously (Kida et al., 2013).
IMMUNOHISTOCHEMISTRY
After fixation in 4% paraformaldehyde, followed by permeabi-
lization and blocking with 0.3% Triton X-100 and 2% skim
milk for cell culture or 5% normal goat serum for brain sec-
tions, cells or sections were incubated at 4◦C overnight in
primary antibodies. Primary antibodies included GFP (1:2000;
final concentration 1.0μg/ml in DAB staining, 1:200; final con-
centration 10μg/ml in fluorescent staining, Molecular Probe;
A11122), Oct3/4 (1:100; final concentration 2.0μg/ml, Santa
Cruz Biotechnology; SC-8628), Nestin (1:200; final concen-
tration 2.5μg/ml, Millipore Biosciences Pharmingen; 556309),
β-Tubulin-III (1:400; final concentration 2.5μg/ml, Covance
Research Products; PRB-435P), Map2ab (1:200; final con-
centration 10μg/ml, Sigma-Aldrich; M1406), GFAP (1:2000,
Millipore Biosciences Pharmingen; AB5804), Ctip2 (1:500; final
concentration 2.0μg/ml, Abcam; ab18465), Cux1 (1:200; final
concentration 1.0μg/ml, Santa Cruz Biotechnology; sc-13024),
Otx1 (1:200, Abnova; H00005013-A01), Vesicular Glutamate
Transporter 1 (VGLUT1) (1:500; final concentration 2.0μg/ml),
Chemicon; MAB5502 and GABA (1:2000, ImmunoStar; 20094).
Appropriate cyanin-3(Cy3)-, FITC-, cyanin-5(Cy5)-labeled sec-
ondary antibodies (Jackson Immunoresearch Laboratories, Inc.,
West Grove, PA) were used at room temperature for 2 h.
For nuclear staining, 4’,6-diamidino-2-phenylindole (DAPI)
(200 ng/mL) was added to the final wash. The immunoreac-
tive cells were detected using either a laser confocal microscope
(Zeiss LSM5) or a fluorescent scope (BZ-8000; Keyence, Osaka,
Japan). The cells in 10 fields were counted in each of 4–6 inde-
pendent experiments. The total number of cells was evaluated
by counting DAPI-positive nuclei. Because sometimes the ven-
dor does not provide the information about concentrations of
optimal-working antibody, we first determined the appropriate
concentration. For initial experiments, we tried dilutions rang-
ing from 1:50 to 1:2000 for immunohistochemical applications.
And then, we determined most suitable concentration or dilution
ratio. The detailed information of primary antibodies we used in
this study was shown in Table 1. Regarding tissue type control, we
referred product sheet information and references that were listed
in it, and then selected the optimal positive and negative control.
Each positive and negative control we used was listed in Table 2.
FUNCTIONAL ANALYSIS
To evaluate balance and motor coordination, mice were tested
at 3 weeks after transplantation for their sensorimotor skills in
both the Rotarod and Beam walking tests, as previously reported
(Daadi et al., 2009). Briefly, in the Rotarod test, the mice were
placed onto a horizontal rotating rod at 4 rpm (Model ENV-
576M; Med Associates, St. Albans, VT, USA), and then the tread-
mill was accelerated from 4 to 40 rpm over the course of a 5-min
trial. A single test lasted from the time that the mouse was placed
on the rotating rod until it fell-off or until 5min had elapsed. The
mice rested in their home cages for 20–30min between each trial.
The average time on the rotating rod is presented. In the Beam
walking test, the beam was 0.6 cm wide and 120 cm in length
and was suspended about 60 cm above foam pads. The average
score (total time spent on beam walking divided by 5 trials) was
calculated for each animal.
STATISTICAL ANALYSIS
All values were expressed as mean ± SD. Statistical comparisons
among each group were determined using a commercially avail-
able software package (JMP 9.0, SAS Institute Inc., Cary, NC).
Data were tested by the Wilcoxon signed-rank test. P < 0.05 was
considered statistically significant.
RESULTS
CHARACTERIZATION OF HYPOXIA-ISCHEMIA INJURY
Macroscopically, the lateral side of the ischemic cerebral hemi-
sphere turned white clearly indicating ischemia and edema at
24 h after the HI insult (Data not shown). TTC staining showed
an ischemic lesion of the cortex in the same region (Figure 1A).
Microscopic examination of the Kluver–Barrela staining showed
loss of pyramidal-shaped neurons in the deep layer (Figure 1C
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Table 1 | Antibodies information used in this study.
Antibody Isotype Concentration Source/Catalog number Host Immunogen
Primary Final
GFP IgG2a 2.0mg/ml 10μg/ml (in
fluorescent)
Molecular Probe/A11122 Mouse Green fluorescent protein
1.0μg/ml (in
DAB)
Oct3/4 Polyclonal 200μg/ml 2.0μg/ml Santa Cruz
Biotechnology/SC-8628
Goat Human Oct-3A/4
Nestin IgG1 0.5mg/ml 2.5μg/ml Millipore Biosciences
Pharmingen/556309
Mouse E15 Rat spinal cord extracts
β-Tubulin-III Polyclonal 1.0mg/ml 2.5μg/ml Covance Research
Products/PRB-435P
Rabbit Rat brain microtubules
Map2ab IgG1 2.0mg/ml 10μg/ml Sigma-Aldrich/M1406 Mouse Bovine MAP2
GFAP Polyclonal Not described 1:2000
dilution
Millipore Biosciences
Pharmingen/AB5804
Rabbit Bovine GFAP
Ctip2 IgG2a 1.0mg/ml 2.0μg/ml Abcam/ab18465 Rat Fusion protein (amino acids of human CTIP2)
Cux1 Polyclonal 2.0μg/ml 1.0μg/ml Santa Cruz
Biotechnology/sc-13024
Rabbit Mouse origin CCAAT displacement protein
(CDP)
Otx1 Polyclonal Not described 1:200 dilution Abnova/H00005013-A01 Mouse Human OTX1 partial recombinant protein
VGLUT1 IgG1 1.0 mg/mL 2.0μg/ml Chemicon/MAB5502 Mouse Rat vesicular glutamate transporter (VGLUT) 1
GABA Polyclonal Not described 1:2000
dilution
ImmunoStar/20094 Rabbit γ(gamma)-aminobutyric acid (GABA) coupled to
bovine serum albumin (BSA)
Table 2 | Tissue type controls used in this study.
Antibody Positive control Negative control
GFP GFP stably expressed ES cells that were constructed from
E14Tg2a.4 (Ideguchi et al., 2010)
Undifferentiated mouse ES cells line, E14Tg2a.
Oct3/4 Day 3.5 blastocysts that were extracted from the uteri of pregnant
mouse female
Postnatal day 1 (P1) mouse brain
Nestin Embryonic day 14 (E14) mouse brain Undifferentiated mouse ES cells line, E14Tg2a
Adult mouse brain
β-Tubulin-III Postnatal day 1 (P1) mouse brain Undifferentiated mouse ES cells line, E14Tg2a
Map2ab Adult mouse brain Undifferentiated mouse ES cells line, E14Tg2a
GFAP Adult mouse brain Undifferentiated mouse ES cells line, E14Tg2a
Mature neurons of adult mouse brain as internal control
Ctip2 Postnatal day 1 (P1) mouse brain Undifferentiated mouse ES cells line, E14Tg2a
Cux1 Postnatal day 1 (P1) mouse brain Undifferentiated mouse ES cells line, E14Tg2a
Otx1 Embryonic day 14 (E14) mouse brain Undifferentiated mouse ES cells line, E14Tg2a
VGLUT1 Adult mouse brain Undifferentiated mouse ES cells line, E14Tg2a
GABA Adult mouse brain Undifferentiated mouse ES cells line, E14Tg2a
and magnified photograph) when compared to the contralateral
cortex (Figure 1B and magnified photograph). In addition, Ctip2
immunostaining, which is a specific marker of layers V and
VI, demonstrated that the number of positive neurons in lay-
ers V–VI (deep layer) was significantly reduced by almost 90%
compared to the contralateral side (Figures 1D,E,H, P = 0.0002).
The thickness of the cortex of the HIE model; 3.44 × 106 μm2,
was also significantly attenuated compared to the contralateral
side; 4.76 × 106 μm2, (Figure 1I, P = 0.036). These findings
are in contrast to the preservation of Cux1-positive superficial
layer neurons (Figures 1D,E,F,G and magnified photographs).
An assessment of the motor function at 3 weeks after HI insult
showed that the HIE model mice had lower scores in the Rotarod
(Figure 2A, P = 0.012) and Beam walking tests (Figure 2B, P =
0.0002).
In vivo NEURONAL DIFFERENTIATION OF ES CELLS TOWARD DEEP
LAYER-SPECIFIC NEURONS
ES cells were placed on a confluent layer of MS5 stromal cells
for neuronal differentiation as done previously (Barberi et al.,
2003; Ideguchi et al., 2010). The neural differentiation profile is
shown in Figure 3I. After 7 days of co-culture, ES cell-derived
colonies were observed, in which the majority (76%) of the
cells expressed nestin that is known as a marker of immature
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FIGURE 1 | Characteristics of hypoxia-ischemia encephalopathy and
motor function. Ischemic lesion of cortex in TTC staining 3 weeks after HI
exposure is shown in (A) with an unstained area. Kluver–Barrela stained
sections show layer V pyramidal neurons in the contralateral cortex (B) that is
presented as a square area with solid line in (A). Magnified insert in (B)
shows monopolar and pyramidal-shaped neurons. On the other hand, layer V
pyramidal-shaped neurons in the ipsilateral cortex are mostly absent (C and
magnified insert) as shown in the square area with a solid line in (A).
Immunostaining shows the mature neuronal marker NeuN, deep layer marker
Ctip2 (D and magnified insert), and superficial marker Cux1 (F and magnified
insert). Ctip2-positive neurons in the ipsilateral cortical area dramatically
decreased (E and magnified insert), while Cux1-positive cells in the superficial
area are comparatively preserved (G and magnified insert). (H) CTIP2 positive
cells of unit-squared area (200 × 200 μm) in randomly selected area in layer V
cortex are represented by ipsilateral/contralateral hemisphere (∗P < 0.0005).
(I) The area of cortex is represented by ipsilateral/contralateral hemisphere
(∗∗P < 0.05). Scale bar: (A) 1000μm; (B,C) 100μm; (D–G) 500μm; (D–G,
magnified insert) 200μm; CC: corpus callosum, V: ventricle, St: striatum.
neural cells (Figures 3B,I) whereas Oct3/4 positive-cells were
hardly expressed, and subsequently were not detectable by day
15 (Figures 3A,I). Approximately 30% of the cells within the
colonies expressed TuJ1 (Figures 3C,I), an early neuronal marker
at day 7. Map2ab-positive mature neurons were less abundant
than other immature neuronal cells at day 7, but increased with
time until day 15 (Figure 3I). The number of GFAP-positive glial
cells increased with time, but was less than 10% of the total cells
(Figure 3I).
We next examined the potential of these MS5 co-cultured
ES-NPCs to differentiate into more specific neurons. Day 7 ES
cell-derived colonies were detached from the MS5 feeder layer,
dissociated into single cells, and then further differentiated for
an additional 8 days on coated slides in Neurobasal medium
before immunohistochemical analysis. Map2ab expression on
day 15 was increased up to ∼70% in all cells (Figure 3D). Cell
staining with deep cortical layer-specificmarkers, Otx1 and Ctip2,
increased significantly between days 5 and 9, and afterward 45–
50% of all cells expressed these genes on day 15 (Figures 3E,F,I).
On day 15, ∼74% of all cells were glutamatergic and 20% were
GABAergic neurons, which was similar to the amounts present in
the normal cortex (Figures 3G,H,J).
ENGRAFTED ES-NPCs EXPRESSED MATURE AND DEEP
LAYER-SPECIFIC NEURONAL MARKERS
To characterize the identity of the cells in the ES cell-derived
graft, we performed immunohistochemical staining in the brains
at 3 weeks after transplantation. GFP-DAB staining showed
apparent engrafted cells in the injured cortex (Figure 4A). The
graft in the HI-injured brain expressed not only the mature
neuronal marker, NeuN, but also the deep layer cortical-neuronal
marker, Ctip2 (Figures 4B,E–G,I–K). Some of the NeuN- positive
and also the Ctip2-positive cells showed monopolar morphol-
ogy suggesting that they were differentiating into deep layer
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FIGURE 2 | Behavioral evaluation at 3 weeks after HI insult. Rotarod
test (A) and Beam walking test (B) show that somatomotor function
disorder in the HIE model mice compared to control group with statistical
significance (∗P < 0.05, ∗∗P < 0.001).
FIGURE 3 | Time course of ES cell neural induction with MS5
co-culture. Colonies of ES cells grown on MS5 cells for 7 days were
immunostained for Oct3/4 (A) and GFP, nestin (B), Tuj1(C), and GFP.
Immunostaining of day 7 MS5-NPCs after an additional 8 days of
differentiation into mature cells on polyornithine/fibronectin (OF)-coated
slides, Map2ab (D), Ctip2 (E), Otx1 (F), VGLUT1 (G), and GABA (H). (I)
Time course of immunostaining for Oct3/4- Nestin-, TuJ1-, Map2ab-, GFAP-,
Otx1-, and Ctip2-positive cells as a percentage of total DAPI-stained cells.
(J) Frequency distribution of glutamatergic and GABAergic neuronal
markers as a percentage of total DAPI stained cells after 15 days of
neuronal differentiation. Scale bar; (A–C), 50 um; (D–H), 25 um.
neurons (Figures 4H,L). ES-NPCs migrated into the deep layer
of the cortex from the core region of the GFP-positive graft and
appeared differentiated to pyramidal neurons morphologically.
These differentiated cells possessed apical dendrites extending
toward the pial surface and axons descending into the subcor-
tical area (Figure 4C). Regarding the composition in the graft,
nearly 45% of all cells were NeuN positive and 12% were Ctip2
positive (Figure 4D). These data showed that ES-NPCs, even if
implanted into an impaired cortex, possess the ability to differ-
entiate into cortical deep layer pyramidal neurons based on both
their morphology and also on their immunohistochemical stain-
ing. Interestingly, a portion of the cells that were unintentionally
injected and/or leaked into the hippocampus survived in the CA1
pyramidal cell layer, and differentiated into CA1 pyramidal neu-
rons with apical dendrites extended into the molecular cell layer.
These cells in the hippocampus also stained with a mature neu-
ronal marker and produced glutamate (Figures 4M–P). These
findings show that deep layer neuron-specified NPCs seems to
migrate into their preferred location, and then differentiate into
region-specific and -functional mature neurons.
ENGRAFTED NEURONS PROJECT AXONS TO SUBCORTICAL BRAIN
LOCATIONS
In most of the grafted animals, we found GFP-positive axonal
sprouting from the graft core into the subcortical target area.
Axons from the sensorimotor cortex area extended into the
ipsilateral side-corpus callosum (Figure 5B), further lateral side
(Figure 5D), striatum (Figure 5E), internal capsule (Figure 5G),
and contralateral corpus callosum (Figure 5C). Furthermore, a
few GFP-positive axons extended into the molecular layer in
the hippocampal CA1 region (Figures 5I,I′). Schematic repre-
sentations determined from the mouse brain of each photo-
graph (Franklin and Paxinos, 2008), (Figure 5A) coronal section,
(Figure 5F) magnified coronal section centering around the inter-
nal capsule, and (Figure 5H) magnified coronal section centering
around the hippocampus.
TRANSPLANTATION OF ES-NPCs IMPROVED MOTOR FUNCTION
To determine the efficacy of the ES-NPCs engraftment for func-
tional recovery, the sensorimotor skills of the animals were eval-
uated using 2 neurobehavioral tests 3 weeks after transplantation.
Our results showed that after 3 weeks, the transplanted HIE
mice significantly improved in the use of their limbs in both the
Rotarod test (Figure 6A, P = 0.0008) and the Beam walking test
(Figure 6B, P = 0.0014) when compared to sham-transplanted
mice.
DISCUSSION
Our goal was to establish a therapeutic strategy for
hypoxia-ischemia encephalopathy (HIE) using NPCs grafted
into the brains of injured mice. We previously reported that
ES cell-derived NPCs engrafted into the neonatal cortex and
generated pyramidal shaped neurons which demonstrated axonal
sprouting into appropriate subcortical-specific areas, thus,
recapitulating the normal brain anatomy (Ideguchi et al., 2010).
ES-NPCs possesses the ability to differentiate into dorsal fore-
brain neurons based on their gene expression profile (Ideguchi
et al., 2010). Some reports demonstrated that pluripotent stem
cell-derived neurons grew and developed neuronal connectivity
with either adult athymic, immunosuppressed, damaged, or nor-
mal neonatal rodent brain (Gaillard et al., 2007; Thompson et al.,
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FIGURE 4 | Neurological differentiation of ES-NPCs 3 weeks after
transplantation into HI-injured brain. (A) DAB staining for GFP antigen
showed that the survived graft located mainly in the cortex. (B) GFP-positive
survived graft cells expressed NeuN, a mature neuronal marker, in the cortex
and partially in the corpus callosum. The square area in (B) shows (E–G) and
(I–K), and the rectangle area shows (H) and (L). (C) Some NPCs migrated
into the cortex from the graft and differentiated into pyramidal-shaped
neurons with apical dendrites. Additional dendrites and axons were observed
in the layer V cortical area. (D) Frequently distribution of neuronal markers,
NeuN and Ctip2, as a percentage of DAPI in the graft. Core region of graft
showed co-localization of NeuN (F) or Ctip2 (J) and GFP (E,I,G,K). Some
NeuN-positive (H) or Ctip2-positive cells (L) demonstrate monopolar
morphology. (M–P) Migrated or leaked NPCs into the hippocampus at
transplantation differentiated to CA1 pyramidal neurons with apical dendrites
and also expressed the Map2ab neuronal marker and glutamate (arrow
heads). Scale bar; (A) 1000 um, (B) 200 um, (C) 20 um, (E–P) 50 um.
2009; Gaillard and Jaber, 2011; Denham et al., 2012; Steinbeck
et al., 2012). Daadi et al. demonstrated that human neural stem
cells which engrafted into the ischemic-injured adult brain had
enhanced axonal sprouting into subcortical target areas, and
increased expression of genes related to neurogenesis, resulting
in motor functional recovery of the animals (Daadi et al., 2010).
However, they emphasized that this functional recovery was not
attributable to reconstruction via engrafted NSCs with host brain
but due to neurotrophic support from those cells. In this study,
we demonstrated axonal sprouting from engrafted cells into the
subcortical target area. Because the location of the transplanted
graft was chiefly in the motor cortex, the axons extended into
the pyramidal tract-related area, i.e., corpus callosum, striatum,
and internal capsule in accordance with normal axonal network
anatomy. Thus, axonal rewiring can be achieved in not only the
normal brain but also in the ischemic-insult brain environment.
Moreover, we have shown that transplanted ES-NPCs expressed
not only the mature neuronal marker, NeuN, but also another
neuronal marker, Ctip2 which was expressed in the deep-layer
cortical and axonal projecting neurons. Ctip2 expression in the
graft supports the interpretation that some component of the
graft can extend axons toward the subcortical region-specific
target area. It is important to establish differentiation procedures
aimed at generating cortical progenitors with different laminar
identities to innervate appropriate target areas after transplanta-
tion. In our HIE insult model, we used animals with an injury
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FIGURE 5 | Axonal outgrowth from the motor cortex transplant.
Schematic representations determined from the mouse brain of each
photograph (Franklin and Paxinos, 2008), (A) coronal section, (F) magnified
coronal section centering around the internal capsule, and (H) magnified
coronal section centering around the hippocampus. Black arrow in (A) shows
cells injection site. GFP-positive axons from the graft entered and extended
within the corpus callosum (CC) just below the injection site (B), lateral side
(D), striatum (E), internal capsule (IC) (G, thin arrows), and also contralateral
CC (C). (I, I’) Axon in the CA1 area in the hippocampus (thick arrows). Scale
bar; (B–E, G) 100 um, (I, I’) 50 um.
FIGURE 6 | Behavioral evaluation 3 weeks after NPCs transplantation
into HI-injured brain. Rotarod test (A) and Beam walking test (B) showed
somatomotor functional recovery in the HIE model mice when compared to
sham transplantation group with statistical significance (∗P < 0.001,
∗∗P < 0.005).
to the deep layer cortex. The ES-NPCs used in this study are
programmed to generate deep layer cortical-projection neurons,
which was compatible with transplantation as a cell replacement
procedure.
With one exception, the expression of a deep layer-specific
marker, such as either Ctip2, Tbr1, Otx1, etc., had not been
confirmed in the graft whereas a mature neuronal marker was
identified (Daadi et al., 2010; Gaillard and Jaber, 2011; Steinbeck
et al., 2012). Denham et al. demonstrated not only a mature neu-
ronal marker but also Ctip2 and Tbr1 expression in the reporter
gene-GFP positive graft. The graft location, however, was near the
pial surface which was an incorrect area for Ctip2 and Tbr1 local-
ization (Denham et al., 2012). In our study, some migrated NPCs
from the graft generated pyramidal-shaped neurons that pos-
sessed extended apical dendrites and axonal projections, which
have neuronal morphology similar to that found in the deep
layer (Figure 4C). These novel findings that were based on appro-
priate engraftment in the cortex, expression of a deep layer
neuronal marker at the correct cortical location, and rewiring via
transplanted cells with the recipient subcortical target area are
important parameters for cell replacement therapy.
It is generally believed that neurons are more sensitive to
the hypoxia-ischemia environment than glial cells because they
have higher energy demands and only they produce glutamate.
In addition, some types of neurons are more vulnerable than
others to this type of adverse environment. For example, the
hippocampal pyramidal cells of CA1, pyramidal neocortical neu-
rons in layers V and VI, Purikinje cells, and striatal neurons
have the highest vulnerability. The HIE in this study was based
on the Rice-Vannucci model with relatively brief insults. In this
model, there is deep layer-selective neuronal cell death, such
as Ctip2-positive deep-layer neurons, in contrast to preserving
Cux1-positive superficial-layer neurons from the medial to
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the lateral side after ischemia (Figures 1D–G) (Vannucci and
Vannucci, 1997). This selective vulnerability may depend on the
difference between early-developed deep-layer neurons and late-
developed superficial-layer neurons (Molyneaux et al., 2007).
However, cortical layer II/III neurogenesis is completed by embry-
onic day 18.3, which can explain why the selective vulnerability
in our model does not correlate with the timing of neuronal
development because we created the HIE model on postnatal
day 2 (Clancy et al., 2001). To summarize these points, the
HIE mice at postnatal day 2 in our study were the appropri-
ate model for making a deep layer selective lesion, a laminar
necrosis model. This model is suitable for evaluation of region-
specific cell replacement, neural network reconstruction, and
motor functional recovery after neural stem cell-transplantation.
In this study, although we targeted the transplant to the cor-
tical deep layer, some cells migrated to another cortical area or
leaked to the subcallosal region, i.e., striatum or hippocampus
unexpectedly. Interestingly, engrafted and leaked NPCs into the
hippocampus differentiated to pyramidal shaped-glutamatergic
neurons with apical dendrites in the pyramidal layer in the CA1
region (Figures 4M–P). The peak of CA1 development in mice is
embryonic day 14.8, which is close to that of the cortical layer V
development (day 14.2) when compared to that of cortical layer
II/III (day 16.9) (Clancy et al., 2001). This fact could explain
why our transplanted NPCs were likely to develop into not only
cortical layer V neurons but also into hippocampal pyramidal
neurons.
Two established motor tasks, namely the Rotarod test and the
Beam walking test, were carried out in this study. The Rotarod
test showed that transplanted animals significantly stayed longer
on the rotating rod (30–35 s) than vehicle-transplanted animals
(20 s). A review of the literature reveals that a 20–30% behav-
ioral improvement after ischemic injury is consistently considered
a robust therapeutic benefit (Borlongan et al., 1998, 2004, 2005;
Chen et al., 2001). One explanation for this functional recovery
might be due to regeneration of the neuronal networks although
the function of the engrafted cells and axonal connectivity have
not been demonstrated yet. On the other hand, we cannot exclude
the possibility that functional recovery was mediated by a neuro-
protective effect of the engrafted neural stem cells. In fact, NSCs
or NPCs are also thought to provide neuroprotective support by
expressing various neurotrophic factors, such as BDNF, GDNF, or
NT3 (Park et al., 2002; Buhnemann et al., 2006; Daadi et al., 2009,
2010). This neurotrophic effect could contribute to cell survival,
further neuronal differentiation, and significant axonal sprouting
(Park et al., 2002; Yasuhara et al., 2008; Daadi et al., 2010).
One would not predict adequate engraftment if the NPCs are
transplanted into an ischemic core lesion because this area is not
an ideal “niche” i.e., it does not possess a significant blood sup-
ply or growth and neurotrophic factors that promote cell survival,
neuronal maturation, and axonal sprouting. On the other hand,
in ischemic penumbra lesions, increased vascularization within
a few days after stroke is associated with neurological recovery
and offers another potential target for cell therapy (Krupinski
et al., 1993; Senior, 2001; Wei et al., 2001). Because the HIE
model used in our study revealed that the ischemic core lesion
was located relatively on the lateral side near the middle cerebral
artery, the location of cell transplantation was expected to tar-
get the boundary adjacent to the penumbra although we cannot
confirm this location when transplanting cells (Figures 1A, 4A).
Similarly, healthy engraftment could not be confirmed in the cells
that were injected into the ischemic core lesion.
In summary, our data show that ES-NPCs transplanted into
the injured cortex of an HIE model mouse are capable of differ-
entiation to pyramidal neurons with axonal growth toward the
subcortical target area and that these grafted cells might be able
to promote motor functional recovery based on the morpholog-
ical evidence demonstrated in this study. Although we have not
demonstrated direct functional recovery due to the graft, these
findings demonstrated the possibility of target-specific innerva-
tion in injured brain. Even though HIE is an important cause
of perinatal mortality and permanent neurological morbidities,
including CP, there is no definite treatment for HIE (Ferriero,
2004). Cell replacement therapy for HIE using neural stem cells
could be a critical part of a novel therapeutic strategy although
we do not know the detailed mechanism of motor functional
recovery after NPCs engraftment.
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